Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Metastatic Hormone Naive Prostate Cancer × Pluvicto × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Hormone Naive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Pluvicto 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04343885 2025-07-11

UpFrontPSMA

Peter MacCallum Cancer Centre, Australia

Phase 2 Active not recruiting

Metastatic Hormone Naive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡